Abstract
Positron emission tomography was used to compare the pharmacokinetics of [11C]methylphenidate in the human brain with the temporal course of the subjective and cardiovascular effects observed after intravenous methylphenidate (0.5 mg/kg). Four subjects were tested twice with [11C]methylphenidate, at baseline and after methylphenidate. All subjects showed almost identical uptake of11C labeled drug in brain, as well as a very similar decrease in binding of [11C]methylphenidate in basal ganglia, after pretreatment with methylphenidate. In contrast, the magnitude of the behavioral and cardiovascular changes induced by methylphenidate varied among the subjects. The temporal course for methylphenidate effects paralleled closely the pharmacokinetics of [11C]methylphenidate in brain for the perception of “restlessness” and for changes in systolic blood pressure and heart rate. In contrast, methylphenidate induced “high”, “anxiety” and changes in diastolic blood pressure decreased rapidly despite long lasting binding of the drug in brain. These results indicate that binding of methylphenidate in brain does not appear to predict individual responses to the drug and that more than one neurotransmitter and/or adaptation process are likely to be involved in the behavioral and cardiovascular effects of methylphenidate.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Angrist B, Lee HKP, Gershon S (1974) The antagonism of amphetamine-induced symptomatology by a neuroleptic. Am J Psychiatry 131:817–819
Angrist B, Rotrosen J, Gershon S (1980) Response to apomorphine, amphetamine and neuroleptics in schizophrenia subjects. Psychopharmacology 67:31–38
Aoyama T, Kotaki H, Sawada Y, Iga T (1994) Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites. Pharm Res 11:407–411
Blaster RL, Schuster CR (1973) Fixed-interval schedule of cocaine reinforcement: effects of dose and infusion duration. J Exp Anal Behav 20:119–129
Bergman J, Madras B, Johnson SE, Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self administration by squirrel monkeys. J Pharmacol Exp Ther 251:150–155
Calligaro DO, Eldefrawi ME (1987) Central and peripheral cocaine receptors. J Pharmacol Exp Ther 243:61–68
Carroll FI, Lewin AH, Boja JW, Kuhar MJ (1992) Cocaine receptor: biochemical characterization and structure-activity relationship to cocaine analogues at the dopamine transporter. J Med Chem 35:969–981
Chait LD (1994) Reinforcing and subjective effects of methylphenidate in humans. Behav Pharmacol 5:281–288
Chait LD, Uhlenhuth EH, Johanson CE (1986) The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol andd-amphetamine in humans. Pharmacol Biochem Behav 24:1665–1672
Chait LD, Uhlenhuth EH, Johanson CE (1987) Reinforcing and subjective effects of several anorectics in normal human volunteers. J Pharmacol Exp Ther 242:777–783
Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR (1992) Noradrenergic neuronal dysregulation in patients with panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatr Scand 86:73–282
Cook EC, Jeffcoat RA, Brine DR (1984) Metabolism and pharmacokinetics of drugs. Contract No. 271-80-3705 to NIDA. Research Triangle Institute, North Carolina, pp 141–147
Corwin RL, Woolverxton WL, Schuster CR, Johanson CE (1987) Anorectics: effects on food intake and self administration in rhesus monkeys. Alcohol Drug Res 7:351–361
de Wit H, Uhlenhuth EH, Johanson CE (1986) Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend 16:341–360
Deminiere IM, Piazza PV, Le Moal M, Simon H (1989) Experimental approach to individual vulnerability to psychostimulant addiction. Neurosci Biobehav Rev 13:141–147
Depue RA, Luciana M, Arbisis P, Collins P, Leon A (1994) Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality. J Person Soc Psychol 67:485–498
Deutch AY, Clark WA, Roth RH (1990) Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res 521:311–315
Ding Y-S, Fowler JS, Volkow ND, Gatley SJT, Logan J, Dewey S, Alexoff D, Wolf AP (1994) Pharmacokinetics and in vivo specificity of [11C]dl-threo-methylphenidate for the presynaptic dopaminergic neuron Synapse 18:152–160
Fischman MW, Schuster CR (1981) Cocaine self administration in humans. Fed Proc 41:241–246
Foltin RW, Fischman MW (1991) Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257:247–261
Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, MacGregor R, Hitzemann R, Logan J, Bendriem B, Gatley J, Christman D (1989) Mapping cocaine-binding sites in human and baboon brain in vivo. Synapse 4:371–377
Fowler JS, Wolf AP, Volkow ND (1990) New directions in positron emission tomography- part II In: Allen RC (ed) Annual reports in medicinal chemistry. Academic Press, New Jersey, pp 261–269
Glassman AHS, Stetner F, Walsh T, Raizman PS, Leiss JI, Cooper TB, Covey LS (1988) Heavy smokers, smoking cessation and clonidine. JAMA 2259:2863–2866
Grace AA (1995) The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drugs Alcohol Depend 37:115–129
Janowsky DS, El-Yousef MK, Davis JM, Sekerke J (1973) Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch Gen Psychiatry 28:185–192
Johanson CE, Fischmann MW (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41:3–52
Joyce PR, Donald RA, Nicholls MG, Lievesey JH, Abbott RM (1986) Endocrine and behavioral responses to methylphenidate in normal subjects. Biol Psychiatry 21:1015–1023
Kavoussi RJ, Coccaro E (1993) The amphetamine challenge test correlates with affective liability in healthy volunteers. Psychiatry Res 48:219–228
Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715–723
Lieberman JA, Alvir J, Geisler S, Ramos-Lorenzi J, Woerner M, Novacenko H, Cooper T, Kane JM (1994) Methylphenidate response, psychopathology and tardive diskinesia as predictors of relapse in schizophrenia. Neuropsychopharmacology 11:107–118
Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, MacGregor RR, Hitzemann R, Bendriem B, Gatley JS, Christman DR (1990) Graphical analyses of reversible radioligand binding from time activity measurements applied toN-11C-methyl-(-) cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740–747
Logan J, Volkow ND, Fowler JS, Wang G-J, Dewey SL, MacGregor R, Schlyer D, Gatley SJ, Pappas N, King P, Hitzemann R, Vitkun S (1994) Effects of blood flow on [11C] raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 14:995–1010
Madras BK, Kaufman MJ (1994) Cocaine accumulates in dopamine-rich regions of primate brain after IV administration: comparison with mazindol distribution. Synapse 18:261–275
Madras B, Fahey MA, Bergman J, Canfield DR, Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. I. [3C] cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131–141
Oldendorf WH (1992) Some relationships between addiction and drug delivery to the brain. In Frankenheim J, Brown RM (eds) bioavailability of drugs to the brain and blood brain barrier. Research Monograph 120, National Institue on Drug Abuse. Rockville, pp 13–25
Parran TV, Jasinski DR (1991) Intravenous methylphenidate abuse. Prototype for prescription drug abuse. Arch Int Med 151:781–783
Patrick KS, Caldwell RW, Ferris RM, Breese GR (1987) Pharmacology of the enantiomers of threo-methylphenidate. J Pharmacol Exp Ther 241:152–158
Perez-Reyes M, DiGuiseppi S, Ondrusek G, Jeffcoat A, Cook CE (1982) Free-base cocaine smoking. Clin Pharmacol Ther 32:459–465
Redmond DE, Huang YH (1979) New evidence for a locus coeruleus norepinephrine connection with anxiety. Life Sci 25:2149–2162
Reith MEA, Sershen H, Allen DL, Lajtha A (1983) A portion of [3H] cocaine binding in brain is associated with serotonergic neurons. Mol Pharmacol 23:600–606
Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277–286
Ritz MC, Lamb RJ, Goldeberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to the self-administration of cocaine. Science 237:1219–1223
Schindler CW, Tella SR, Erzouki HK, Goldberg SR (1995) Pharmacological mechanisms in cocaine's cardiovascular effects. Drug Alcohol Depend 37:183–191
Sherer MA, Kumor KM, Jaffe JH (1989) Effects of intravenous cocaine are partially attenutated by haloperidol. Psychiatry Res 27:117–125
Schweri MM, Skolnick P, Rafferty MF, Rice KC, Janowsky AJ, Paul SM (1985) [3H]Threo-(±)-methylphenidate uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. J Neurochem 45:1062–1070
Seeman P (1993) Receptor tables. Vol 2. Drug dissociation for neuroreceptors and transporters. Sz Research, Toronto
Srinivas NR, Hubbard JW, Quinn D, Korchinski ED, Midha KK (1991) Extensive and enantioselective presystemic metabolism of dl-threo-methylphenidate in humans. Prog Neuro Psychopharmacol Biol-Psychiatry 5:213–220
Stathis M, Scheffel U, Lever SZ, Boja JW, Carroll IF, Kuhar MJ (1995) Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology (in press)
Van Kammen D, Bunney WE, Docherty JP, Marder SR, Ebert MH, Rosenblatt JE, Rayner JN (1982)d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia. Am J Psychiatry 139:991–997
Verebey K, Gold MS (1988) From coca leaves to crack: the effects of dose and routes of administration in abuse liability. Psyhiatr Ann 18:513–520
Volkow ND, Fowler JS, Wolf AP, Wang G-J, Logan J, MacGregor R, Dewey SL, Schlyer DJ, Hitzemann R (1992) Distribution of11C-cocaine in human heart, lungs, liver and adrenals. A dynamic PET study. J Nucl Med 33:521–525
Volkow ND, Wang G-J, Fowler JS, Logan J, Schlyer D, Hitzemann R, Liebermann J, Angrist B, Pappas N, MacGregor R, Burr G, Cooper T, Wolf AP (1994) Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 16:255–262
Volkow ND, Ding U, Fowler JS, Wang G-J, Logan J, Gatley JS, Dewey SL, Ashby C, Lieberman J, Hitzemann R, Wolf AP (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatry 52:456–463
Von Felsinger JM, Lasagna L, Beecher HK (1995) Drug-induced mood changes in man. 2. Personality and reactions to drugs. JAMA 157:1113–1119
Wang G-J, Volkow ND, Hitzemann R, Wong C, Angrist B, Burr G, Pascani K, Pappas N, Lu A, Cooper T, Lieberman J (1995) Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. Eur Addict Res (in press)
Wilens TE, Biederman J (1992) The stimulants. Pediatr Psychopharmacol 15:191–222
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Volkow, N.D., Wang, G.J., Gatley, S.J. et al. Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects. Psychopharmacology 123, 26–33 (1996). https://doi.org/10.1007/BF02246277
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246277